Journal Article

Differences in brain structure and cognitive performance between patients with long-COVID and those with normal recovery

Stoessl, A. Jon, Grier, Ava, Sossi, Vesna, Sekhon, Mypinder S., Farah, Lea N., Chen, Johnson, Nelson, Breanna K., Lang, Donna, Su, Wayne, Honer, William G., Wellington, Cheryl, Silverberg, Noah D., Panenka, William J.

2024

Overview

•Long-COVID is heterogeneous in its symptoms, severity, and illness duration.•There was no association between long-COVID and cognitive performance.•Cognitive symptoms may represent functional cognitive disorders.•Long-COVID had lower mean diffusivity on diffusion imaging than normal recovery.•Diffusion imaging differences may suggest gliosis as a mechanism of long-COVID. The pathophysiology of protracted symptoms after COVID-19 is unclear. This study aimed to determine if long-COVID is associated with differences in baseline characteristics, markers of white matter diffusivity in the brain, and lower scores on objective cognitive testing. Individuals who experienced COVID-19 symptoms for more than 60 days post-infection (long-COVID) (n = 56) were compared to individuals who recovered from COVID-19 within 60 days of infection (normal recovery) (n = 35). Information regarding physical and mental health, and COVID-19 illness was collected. The National Institute of Health Toolbox Cognition Battery was administered. Participants underwent magnetic resonance imaging (MRI) with diffusion tensor imaging (DTI). Tract-based spatial statistics were used to perform a whole-brain voxel-wise analysis on standard DTI metrics (fractional anisotropy, axial diffusivity, mean diffusivity, radial diffusivity), controlling for age and sex. NIH Toolbox Age-Adjusted Fluid Cognition Scores were used to compare long-COVID and normal recovery groups, covarying for Age-Adjusted Crystallized Cognition Scores and years of education. False discovery rate correction was applied for multiple comparisons. There were no significant differences in age, sex, or history of neurovascular risk factors between the groups. The long-COVID group had significantly (p < 0.05) lower mean diffusivity than the normal recovery group across multiple white matter regions, including the internal capsule, anterior and superior corona radiata, corpus callosum, superior fronto-occiptal fasciculus, and posterior thalamic radiation. However, the effect sizes of these differences were small (all β<|0.3|) and no significant differences were found for the other DTI metrics. Fluid cognition composite scores did not differ significantly between the long-COVID and normal recovery groups (p > 0.05). Differences in diffusivity between long-COVID and normal recovery groups were found on only one DTI metric. This could represent subtle areas of pathology such as gliosis or edema, but the small effect sizes and non-specific nature of the diffusion indices make pathological inference difficult. Although long-COVID patients reported many neuropsychiatric symptoms, significant differences in objective cognitive performance were not found.

• Publisher: Elsevier Inc,Elsevier Limited,Elsevier
• Subject: Adult / Aged / Anisotropy / Brain - diagnostic imaging / Brain - pathology / Brain research / Cognition & reasoning / Cognition - physiology / Cognitive ability / Corpus callosum / COVID-19 / COVID-19 - diagnostic imaging / COVID-19 - pathology / Diffusion tensor imaging / Diffusion Tensor Imaging - methods / Edema / Female / Gliosis / Humans / Illnesses / Infections / Long COVID / Magnetic resonance imaging / Magnetic Resonance Imaging - methods / Male / Medical imaging / Middle Aged / MRI / Neuroimaging / Neuropsychological Tests / Post-Acute COVID-19 Syndrome / Questionnaires / Risk factors / SARS-CoV-2 / Sensitivity analysis / Severe acute respiratory syndrome coronavirus 2 / Statistical analysis / Substantia alba / Thalamus / White Matter - diagnostic imaging / White Matter - pathology